1. Home
  2. EBON vs AYTU Comparison

EBON vs AYTU Comparison

Compare EBON & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$3.35

Market Cap

21.4M

Sector

Technology

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.65

Market Cap

23.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
AYTU
Founded
2010
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
23.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
EBON
AYTU
Price
$3.35
$2.65
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
21.8K
156.8K
Earning Date
08-15-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,337,066.00
$63,696,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$47.32
P/E Ratio
N/A
N/A
Revenue Growth
104.28
N/A
52 Week Low
$2.96
$0.95
52 Week High
$6.65
$3.07

Technical Indicators

Market Signals
Indicator
EBON
AYTU
Relative Strength Index (RSI) 46.79 55.02
Support Level $3.45 $2.60
Resistance Level $3.60 $2.72
Average True Range (ATR) 0.15 0.17
MACD 0.04 -0.01
Stochastic Oscillator 56.83 33.30

Price Performance

Historical Comparison
EBON
AYTU

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: